These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 7778884

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC.
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract] [Full Text] [Related]

  • 23. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 24. Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
    Young JB.
    Eur Heart J; 1993 Jul; 14 Suppl C():14-7. PubMed ID: 8365422
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Physiopathology of left ventricular remodeling after myocardial infarction].
    Bassand JP, Anguenot T.
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():43-9. PubMed ID: 1838920
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ.
    Basic Res Cardiol; 1993 Dec; 88 Suppl 1():1-14. PubMed ID: 8395169
    [Abstract] [Full Text] [Related]

  • 32. [Expansion of infarction, dilatation and ventricular remodelling. Therapeutic potential of angiotensin-converting enzyme inhibitors].
    de Sá ME.
    Rev Port Cardiol; 1992 Mar; 11(3):267-72. PubMed ID: 1610613
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery disease.
    Adams KF.
    Coron Artery Dis; 1998 Mar; 9(10):675-84. PubMed ID: 9894619
    [Abstract] [Full Text] [Related]

  • 34. RAS and connective tissue in the heart.
    Sun Y, Weber KT.
    Int J Biochem Cell Biol; 2003 Jun; 35(6):919-31. PubMed ID: 12676176
    [Abstract] [Full Text] [Related]

  • 35. Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.
    St John Sutton M, Pfeffer MA.
    Cardiologia; 1994 Dec; 39(12 Suppl 1):27-30. PubMed ID: 7634281
    [Abstract] [Full Text] [Related]

  • 36. [Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene].
    Tereshchenko SN, Dzhaiani NA, Moiseev VS, Nosikov VV.
    Kardiologiia; 2002 Dec; 42(5):38-41. PubMed ID: 12494147
    [No Abstract] [Full Text] [Related]

  • 37. Beyond remodeling: a new paradigm for angiotensin-converting enzyme inhibitors following myocardial infarction.
    Solomon SD.
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S31-4. PubMed ID: 11392477
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ventricular remodeling following myocardial infarction: a description of the pathologic process, current investigation, and suggested therapy.
    Fara AM.
    Crit Care Nurs Clin North Am; 1992 Jun; 4(2):325-37. PubMed ID: 1599655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.